Your Article Summary
See Latest ArticlesThe ENDOTRIAL Study: A Spontaneous, Open-Label, Randomized, Multicenter, Crossover Study on the Efficacy of Sildenafil, Tadalafil, and Vardenafil in the Treatment of Erectile Dysfunction
The Journal of Sexual Medicine, 07/02/09
Jannini EA et al. - An overall equivalence was demonstrated in the subjective perception of treatment benefits for all the PDE5i tested. However, sildenafil, in a dose-dependent manner, was the unique PDE5i able to ameliorate some of the penile flow parameters within the 8-week treatment period. These findings should be interpreted conservatively because of the observational nature of the study.
Related Articles
Hormonal Testing and Pharmacologic Treatment of Erectile Dysfunction: A Clinical Practice Guideline From the American College of Physicians
Annals of Internal Medicine, 10/30/09
Relevance Score: 70%
Effects of 12-Month Tadalafil Therapy for Erectile Dysfunction on Couple Relationships: Results from the DETECT Study
The Journal of Sexual Medicine, 10/28/09
Relevance Score: 69%
Evaluation of Microalbuminuria in Patients with Erectile Dysfunction
The Journal of Sexual Medicine, 10/07/09
Relevance Score: 69%
New Drug Udenafil for Erectile Dysfunction in US Trials
Internet Source, 11/10/09
Relevance Score: 68%
The Association of Serum Prolidase Activity and Erectile Dysfunction
Journal of Andrology, 10/23/09
Relevance Score: 68%
Today in Clinical Pharmacology...keeping you current
Receive free subspecialty "5-minute updates" via email
The Statin Choice decision aid in primary care: A randomized trial
Patient Education and Counselling, 12/04/09
Prasugrel for acute coronary syndromes: Faster, more potent, but higher bleeding risk
Cleveland Clinic Journal of Medicine, 12/04/09
Q: Is an ACE inhibitor plus an ARB more effective than either drug alone?
Cleveland Clinic Journal of Medicine, 12/04/09